SAFEPASS 2 clinical study of the Emboliner embolic protection catheter

Emboline completes enrolment in SAFEPASS 2 clinical trial

Emboline has completed enrolment in its SAFEPASS 2 clinical study of the Emboliner embolic protection catheter. A press release from the company, which develops...

BIBA Briefings: Sapien 3 becomes first TAVI valve to be approved for low-risk patients...

Edwards Lifesciences has received the CE mark for its Sapien 3 transcatheter aortic valve implantation (TAVI) device to be used to manage aortic stenosis...

Routine anticoagulation with rivaroxaban after TAVI harmful: GALILEO trial results

George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late-breaking trial session at the American Heart Association Scientific Sessions (AHA 2019;...

BIBA Briefings: Longest and largest follow-up data for Watchman supports its role in stroke...

Data from the CAP and CAP2 registries—which contain the longest and largest follow-up of patients—add to previous evidence that left atrial appendage closure (LAAC)...
Nicolas van Mieghem

Nicolas van Mieghem

Ehtisham Mahmud

Adrian Banning